XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,042 | +12.2% | 11,623 | +26.4% | 0.00% | 0.0% |
| Q2 2023 | $353,931 | +6.3% | 9,193 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $333,098 | -10.5% | 9,307 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $372,180 | +54.4% | 9,439 | +41.6% | 0.00% | +100.0% |
| Q3 2022 | $241,000 | +18.7% | 6,667 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $203,000 | -1.5% | 6,667 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $206,000 | -31.1% | 6,733 | -29.6% | 0.00% | 0.0% |
| Q4 2021 | $299,000 | +367.2% | 9,565 | +127.7% | 0.00% | – |
| Q3 2021 | $64,000 | -15.8% | 4,201 | +2.7% | 0.00% | – |
| Q2 2021 | $76,000 | +4.1% | 4,091 | 0.0% | 0.00% | – |
| Q1 2021 | $73,000 | – | 4,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |